Chao-Jung Tsao

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Hepatology, Medicine, Cancer Management +12

Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With Lymphoma

Ann‐Lii Cheng, Chao A. Hsiung, Ih‐Jen Su et al. · Hepatology · 2003 · 291 citations · Full text

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

Ann‐Lii Cheng, Zhongzhen Guan, Zhendong Chen et al. · European Journal of Cancer · 2012 · 261 citations · Full text

Baseline Status, Hepatology, Medicine +10

Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease

Yin‐Hsun Feng, Chao‐Liang Wu, Chao-Jung Tsao et al. · Cancer Biology & Therapy · 2011 · 75 citations · Full text

Pathology, Cancer Biology, Tumor Biology +16

The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens

Yi-Ying Wu, Hung-Chang Wu, Jia-En Wu et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 59 citations · Full text